Abdominal obesity

Current Opinion in Lipidology

Volumn 9, Issue 1, 1998, Pages 35-40

  Carey, David G P ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FEMALE; GENDER; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; INHERITANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID STORAGE; LIPOLYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SKINFOLD THICKNESS;

ABDOMEN; ADIPOSE TISSUE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; OBESITY;

EID: 0031961785     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199802000-00008     Document Type: Review

References (80)

1. Ross R, Fortier L, Hudson R. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women. Diabetes Care 1996; 19:1404-1411. Forty obese women had total IAF and total body subcutaneous fat measured by multislice MRI. In addition, IAF was subdivided into intraperitoneal and retroperitoneal fat volume. Correlation with glucose metabolism (oral glucose tolerance test) showed that IAF had the strongest correlation with insulin resistance after controlling for the influence of whole body subcutaneous fat. In addition, the metabolic correlations were not improved by segmenting IAF into intra-peritoneal and retroperitoneal adipose tissue.
2. -2) had increased abdominal fat that was matched with decreased insulin sensitivity.
3. Rissanen P, Hamalainen P, Vanninen E, Tenhuneneskelinen M, Uusitupa M. Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy x-ray absorptiometry in obese middle-aged women. Int J Obesity 1997; 21:367-371.
4. Peiris A, Sothmann M, Hennes M, Lee M, Wilson, C, Gustafson A, et al. Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women. Am J Clin Nutr 1989; 49:758-764.
5. Despres J, Nadeau A, Trembley A, Ferland M, Moorjani S, Lupien P, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989; 38:304-309.
6. Zamboni M, Armellini F, Harris T, Turcato E, Micciolo R. Berganoardreis IA, et al. Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 1997; 66:111-115.
7. Park KS, Rhee B, Lee K-U, Kim S, Lee H, Koh C, et al. Intra-abdominal fat is associated with decreased insulin sensitivity in healthy young men. Metabolism 1991; 40:600-603.
8. Cefalu WT, Wang ZQ, Werbel S, Bell Farrow A, Crouse JR 3rd, Hinson WH, et al. Contribution of visceral fat mass to the insulin resistance of aging. Metabolism 1995; 44:954-959.
9. Whitiker R, Wright J, Pepe M, Seidel K, Dietz W. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1977; 337:869-873.
10. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40:2002-2009.
11. Brambilla P, Manzoni P, Sironi S, Simone P, Del Maschio A, di Natale B, et al. Peripheral and abdominal adiposity in childhood obesity. Int J Obes Relat Metab Disord 1994; 18:795-800.
12. Caprio S, Hyman LD, Mccarthy S, Lange R, Bronson M, Tamborlane WV. Fat distribution and cardiovascular risk factors in obese adolescent girls - importance of the intraabdominal fat depot. Am J Clin Nutr 1996; 64:12-17.
13. Kortelainen ML. Association between cardiac pathology and fat tissue distribution in an autopsy series of men without premortem evidence of cardiovascular disease. Int J Obesity 1996; 20:245-252.
14. Kortelainen ML, Sarkioja T. Extent and composition of coronary lesions and degree of cardiac hypertrophy in relation to abdominal fatness in men under 40 years of age. Arterioscler Thromb Vasc Biol 1997; 17:574-579. There was an association between WHR, more so than IAF, and severity of lesions in the coronary tree. Heart weight, however, correlated with IAF and most closely with perirenal fat.
15. Ronnemaa T, Koskenvuo M, Marniemi J, Koivvnen T, Sajantila A, Rissanen A, et al. Glucose metabolism in identical twins discordant for obesity - the critical role of visceral fat. J Clin Endocrinol Metabol 1997; 82:383-387. This Finnish group identified 50 identical twins out of a registry of 1500 pairs who were discordant for obesity by a mean of 18 kg and performed an oral glucose tolerance test. Body fat distribution was measured by MRI. In genetically identical subjects, the intrapair differences in insulin sensitivity were inversely correlated with IAF but not subcutaneous fat or total body fat.
16. Ross R, Leger L, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992; 72:787-795.
17. Ross R, Shaw KD, Martel Y, de Guise J, Avruch L. Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr 1993; 57:470-475.
18. Ross R, Shaw KD, Rissanen J, Martel Y, de Guise J, Avruch L. Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. Am J Clin Nutr 1994; 59:1277-1285.
19. Bjorntorp P. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Ateriosclerosis 1990; 10:493-496.
20. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991; 40:1397-1403.
21. Krai JG, Schaffner F, Pierson RN Jr, Wang J. Body fat topography as an independent predictor of fatty liver. Metabolism 1993; 42:548-551.
22. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM [see comments]. Int J Obes Relat Metab Disord 1995; 19:846-850.
23. Goto T, Onuma T, Takebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic japanese subjects. Int J Obesity 1995; 19:841-845.
24. Marks SJ, Moore NR, Ryley NG, Clark ML, Pointon JJ, Strauss BJ, et al. Measurement of liver fat by MRI and its reduction by dexfenfluramine in NIDDM. Int J Obes Relat Metab Disord 1997; 21:274-279. An MRI chemical shift technique was validated by liver biopsy in 19 subjects. MRI liver fat index accounted for 76% of the variance biopsy fat. This MRI liver fat index was then measured before and after weight loss. Liver fat correlated close with baseline IAF and changes in liver fat correlated closely with reductions in IAF.
25. Cigolini M, Targher G, Agostino G, Tonoli M, Muggeo M, Desandre G. Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men - role of the metabolic syndrome. Thromb and Haemost 1996; 76:69-73. Liver steatosis, measured by ultrasound in healthy men, was associated with increased PAI-1, F-VIIc and decreased t-PA. These associations could be in part caused by coexistence of high triglyceride and insulin levels.
26. Ryu JE, Craven TE, MacArthur RD, Hinson WH, Bond MG, Hagaman AP, Crouse JR, et al. Relationship of intraabdominal fat as measured by magnetic resonance imaging to postprandial lipemia in middle-aged subjects. Am J Clin Nutr 1994; 60:586-591.
27. Wideman L, Kaminsky LA, Whaley MH. Postprandial lipemia in obese men with abdominal fat patterning. J Sports Med Phys Fitness 1996; 36:204-210.
28. Cassader M, Gambino R, Ruiu G, Marena S, Bodoni P, Pagano G. Postprandial triglyceride-rich lipoprotein changes in elderly and young subjects. Aging Clin Exp Res 1996; 8:421-428.
29. Coppack SW. Postprandial lipoproteins in non-insulin-dependent diabetes mellitus. Diabetic Med 1997; 14 (Suppl 3):74.
30. Karpe F. Mechanisms of postprandial hyperlipidaemia - remnants and coronary artery disease. Diabetic Med 1997; 14 (Suppl 3):66.
31. Phillips D, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R, et al. Intramuscular triglyceride and muscle insulin sensitivity - evidence for a relationship in nondiabetic subjects. Metabol Clin Exp 1996; 45:947-950.
32. Oakes ND, Camilleri S, Furler SM, Chisholm DJ, Kraegen EW. The insulin sensitizer, brl 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabol Clin Exp 1997; 46:935-942.
33. Grimaldi PA, Teboul L, Inadera H, Gaillard D, Amri EZ. Trans-differentiation of myoblasts to adipoblasts - triggering effects of fatty acids and thiazolidinediones. Prostaglandins Leukot & Essen Fatty Acids 1997; 57:71-75.
34. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46:3-10.
35. Chisholm DJ, Campbell LV, Kraegen EW. Pathogenesis of the insulin resistance syndrome (syndrome x). Clin Exp Pharmacol Physiol 1997; 24:782-784.
36. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44:863-870.
37. Lindahl B, Asplund K, Eliasson M, Evrin PE. Insulin resistance syndrome and fibrinolytic activity - the Northern Sweden Monica Study. Int J Epidemiol 1996; 25:291-299.
38. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhanvague I. Production of plasminogen activator inhibitor 1 by human adipose tissue - possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46:860-867. Incubated omental tissue explants produced more PAI-1 antigen than did subcutaneous tissue, whereas similar leptin production was demonstrated.
39. Mansfield MW, Stickland MH, Grant PJ. Pai-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes - metabolic and genetic associations. Thromb & Haemost 1997; 77:357-361.
40. Tsigos C, Chala E, Kyrou I, Economidou C, Stavridis J, Katsilambros N. Association between circulating TNF a concentrations and visceral fat distribution. Int J Obesity 1997; 21:S2-S21.
41. Hennes M, Oshaughnessy IM, Kelly TM, Labelle P, Egan BM, Kissebah AH. Insulin-resistant lipolysis in abdominally obese hypertensive individuals -role of the renin-angiotensin system. Hypertension 1996; 28:120-126.
42. 2. IAF and trunk fat correlated positively and leg fat negatively with atherogenic lipid profiles.
43. Bjorntorp P. The regulation of adipose tissue distribution in humans [review]. Int J Obesity 1996; 20:291-302.
44. Campbell LV, Carey DG, Chisholm DJ. Measurement of central adiposity - a bet each way. Diabetes Care 1996; 19:1033-1034.
45. Abate N, Garg A, Peshock R, Stray-Gundersen J, Grundy S. Relationships of generalised and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96:88-98.
46. Fujimoto WY, Bergstrom RW, Boyko EJ, Leonetti DL, Newell Morris LL, Wahl PW. Susceptibility to development of central adiposity among populations. Obes Res 1995; 3 (Suppl 2):179S-186S.
47. Sparrow D, Borkan GA, Gerzof SG, Wisniewski C, Silbert CK. Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study. Diabetes 1986; 35:411-415.
48. Terry RB, Stefanick ML, Haskell WL, Wood PD. Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: possible protective effects of thigh fat. Metabolism 1991; 40:733-740.
49. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. JCI 1996; 98:1575-1584.
50. Ascarso JF, Sales J, Merchante A, Real J, Lrente R, Martinez-Valls J, Carmera R, et al. Influence of obesity on plasma lipoproteins, glycaemia, and insulinaemia in patients with familial combined hyperlipidemia. Int J Obesity 1997; 21:360-366. Sixty-seven patients with familial combined hyperlipidaemia with a mean body mass index of 27 were compared with a healthly control group matched for age and body mass index. Patients with familial combined hyperlipidemia had higher insulin and glucose AUC after an oral glucose tolerance test than control individuals. This finding was present in non-obese and obese patients. In patients with a body mass index <27, 25-68% were hyperinsulinaemic compared with 0-4% in control individuals.
51. Vohl MC, Tchernof A, Dionne FT, Moorjani S, Prodhomme D, Bouchard C, et al. The apob-100 gene ecori polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apob and dense IdI phenotype in men. Diabetes 1996; 45:1405-1411.
52. Hokanson JE. Lipoprotein lipase gene variants and risk of coronary disease - a quantitative analysis of population-based studies [review]. Int J Clin Lab Res 1997; 27:24-34.
53. Simoneau JA, Colberg SR, Thaete FL, Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. Faseb J 1995; 9:273-278.
54. Kurabayashi T, Carey D, Morrison NA. The beta-3-adrenergic receptor gene trp64arg mutation is overrepresented in obese women - effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 1996; 45:1358-1363.
55. Marks SJ, Moore NR, Ryley NG, Clark ML, Pointon JJ, Strauss B, Hockaday T, et al. Measurement of liver fat by MRI and its reduction by dexfenfluramine in NIDDM. Int J Obesity 1997; 21:274-279.
56. Lemieux S, Prudhomme P, Bouchard C, Tremblay A, Despres JP. Single threshold value of waist girth identified normal-weight and over-weight subjects with excess visceral adipose tissue. Am J Clin Nutr 1996; 64:685-693.
57. Lemieux S, Prudhomme D, Tremblay A, Bouchard C, Despres JP. Anthropometric correlates to changes in visceral adipose tissue over 7 years in women. Int J Obesity 1996; 20:618-624.
58. Abe T, Sakurai T, Kurata J, Kawakami Y, Fukunaga T. Subcutaneous and visceral fat distribution and daily physical activity - comparison between young and middle aged women. Brit J Sports Med 1996; 30:297-300.
59. Hunter G, Kekes-Szabo T, Treuth M, Williams M, Goran M, Pichon C. Intra-abdominal adipose tissue, physical activity and cardiovascular risk in pre- and post-menopausal women. Int J Obesity 1996; 20:860-865. Further analysis of the women studied in [42] showed that the relationship between physical activity and atherogenic lipids profile was not significant after adjustment for IAF and menopausal status. They suggest that the protective role of physical activity may be largely mediated through a reduction in IAF.
60. Bouchard C, Despres J-P, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 1993; 14:72-93.
61. Bouchard C, Rice T, Lemieux S, Despres JP, Perusse L, Rao DC. Major gene for abdominal visceral fat area in the Quebec family study. Int J Obesity 1996; 20:420-427. Three hundred and sixty-six adults from 100 nuclear families underwent abdominal computed tomography and underwater weighing. Adjusting for age, 70% of the variance in total abdominal fat could be explained by familial factors. Heritability estimates, adjusted for age and total fat, were 56% for IAF and 46% for abdominal subcutaneous fat.
62. Carey D, Nguyen TV, Campbell LV, Chisholm DJ, Kelly P. Genetic influences on central abdominal fat - a twin study. Int J Obesity 1996; 20:722-726. In 86 non-obese Australian female twins, DEXA was used to measure central abdominal fat and non-abdominal fat. A strong genetic influence (approximately 70% of the population variance) was demonstrated on central abdominal fat both before and after adjustment for genetic influences on total body fat. This suggests the existence of genes specific for abdominal obesity.
63. Bouchard C, Tremblay A. Genetic influences on the response of body fat and fat distribution to positive and negative energy balances in human identical twins. J Nutr 1997; 127 (Suppl 5):947.
64. Buemann B, Vohl MC, Chagnon M, Chagnon YC, Gagnon J, Perusse L, et al. Abdominal visceral fat is associated with a bcli restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obesity Res 1997; 5:186-192.
65. Yamada K, Yuan X, Ishiyama S, Koyama K, Ichikawa F, Koyanagi A, et al. Association between ala54thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 1997; 40:706-710.
66. Lapsys N, Furler S, Carey D, Moore K, Nguyen T, Herzog H, et al. The relationship of a novel polymorphic marker near the human obese (ob) gene to fat mass in health women. Obesity Res 1997, in press.
67. Dua A, Hennes MI, Hoffmann RG, Maar DL, Krakower GR, Sonnerberg GE, Kissebah AH, et al. Leptin - a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 1996; 45:1635-1637.
68. Ronnemaa T, Karonen SL, Rissanen A, Koskenvuo M, Koivisto VA. Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity. Ann Int Med 1997; 126:26-31.
69. Shimizu H, Shimomura Y, Hayashi R, Ohtani K, Sato N, Futawatari T, et al. Serum leptin concentration is associated with total body fat mass, but not abdominal fat distribution. Int J Obesity 1997; 21:536-541.
70. Rissanen J, Kuopusjarvi M, Pihlajamaki J, Sipilainen R, Heikkinen S, Vanhala M, et al. The trp64arg polymorphism of the beta (3)-adrenegic receptor gene - lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 1997, 20:1319-1323.
71. Gagnon J, Mauriege P, Roy S, Sjostrom D, Chagnon YC, Dionne FT, et al. The trp64arg mutation of the beta-3 adrenergic receptor gene has no effect on obesity phenotypes in the quebec family study and Swedish obese subjects cohorts. J Clin Invest 1996; 98:2086-2093.
72. Lemieux S, Prudhomme D, Bouchard C, Tremblay A, Despres JP. Sex differences in the relation of visceral adipose tissue to total body fatness. Am J Clin Nutr 1993; 58:463-467.
73. Carey DGP, Campbell LV, Chisholm DJ. Is visceral fat (intra-abdominal and hepatic) a major determinant of gender differences in insulin resistance and dyslipidaemia? Diabetes 1996; 45:110A.
74. Elbers J, Asscheman H, Seidell JC, Megens J, Gooren L. Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metabol 1997; 82:2044-2047.
75. Marin P, Lonn L, Andersson B, et al. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men - effects of testosterone. J Clin Endocrinol Metabol 1996; 81:1018-1022.
76. Panotopoulos G, Ruiz JC, Raison J, Guygrand B, Basdevant A. Menopause, fat and lean distribution in obese women. Maturitas 1996; 25:11-19.
77. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabol Clin Exp 1991; 40:1323-1326.
78. Vahl N, Jorgensen J, Skjaerbaek C, Veldhuis JD, Orskov H, Christiansen JS. Abdominal adiposity rather than age and sex predicts mass and regularity of Gh secretion in healthy adults. Am J Physiol Endocrinol Metabol 1997, 35:E1108-E1116.
79. Jorgensen J, Vahl N, Hansen TB, Thuesen L, Hagen C, Christiansen JS. Growth hormone vs. placebo treatment for one year in growth hormone deficient adults - increase in exercise capacity and normalization of body composition. Clin Endocrinol 1996; 45:681-688.
80. Johannsson G, Marin P, Lonn L, et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metabol 1997; 82:727-734.